<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02405195</url>
  </required_header>
  <id_info>
    <org_study_id>SahlgrenskaUHThoraxLL0</org_study_id>
    <nct_id>NCT02405195</nct_id>
  </id_info>
  <brief_title>Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)</brief_title>
  <acronym>ECCSTUD</acronym>
  <official_title>Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute kidney injury is a common complication after cardiac surgery with cardiopulmonary
      bypass (CPB). This study aims to investigate the effects of CPB on renal perfusion,
      filtration and oxygenation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After approval of the regional ethics committee, patients (n=16) undergoing combined cardiac
      surgery procedures during normothermic CPB will be included after informed consent. Systemic
      and renal variables will be measured by pulmonary artery and renal vein catheters. Glomerular
      filtration rate (GFR) will be measured by renal extraction of 51Cr-EDTA and renal blood flow
      (RBF) by the infusion clearance technique for para-aminohippuric acid (PAH) corrected for by
      renal extraction of PAH. Repeated measures ANOVA followed by Fisher's PLSD post-hoc test were
      used for statistical analyses
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Renal Blood Flow (RBF)</measure>
    <time_frame>6 hours</time_frame>
    <description>Renal blood flow measured with PAH clearance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glomerular Filtration Rate (GFR)</measure>
    <time_frame>6 hours</time_frame>
    <description>GFR measured by renal extraction of 51Cr-EDTA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Renal Oxygenation</measure>
    <time_frame>6 hours</time_frame>
    <description>Renal oxygen extraction, defined as renal oxygen consumption divided by renal oxygen delivery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Excretion of NAG</measure>
    <time_frame>24 hours</time_frame>
    <description>Urinary biomarker of tubular renal injury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development of Acute Kidney Injury (AKI)</measure>
    <time_frame>72 hours</time_frame>
    <description>AKI according to AKIN criteria</description>
  </secondary_outcome>
  <enrollment type="Actual">28</enrollment>
  <condition>Complication of Extracorporeal Circulation</condition>
  <condition>Renal Impairment</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cardiopulmonary bypass</intervention_name>
    <description>During cardiac surgery, the subjects are routinely undergoing cardiopulmonary bypass</description>
    <other_name>extracorporeal circulation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Elective complex cardiac surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preserved left ventricular function (LVEF &gt; 50%)

          -  Normal preoperative S-creatinine

        Exclusion Criteria:

          -  Contraindications to radiocontrast

          -  Cardiac transplantation och dissection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sven-Erik Ricksten, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska Academy, dept of clinical science</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of thoracic anesthesia, Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>March 27, 2015</study_first_submitted>
  <study_first_submitted_qc>March 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2015</study_first_posted>
  <results_first_submitted>April 27, 2018</results_first_submitted>
  <results_first_submitted_qc>February 4, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 7, 2019</results_first_posted>
  <last_update_submitted>February 4, 2019</last_update_submitted>
  <last_update_submitted_qc>February 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Lukas Lannemyr</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>CardioPulmonaryBypass</title>
          <description>Open cardiac surgery with normothermic Cardiopulmonary Bypass at 2.5 L/min/m2.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CardioPulmonary Bypass</title>
          <description>Open cardiac surgery with normothermic Cardiopulmonary Bypass at 2.5 L/min/m2.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="18"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Sweden</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Serum creatinine</title>
          <units>micromol per litre</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left ventricular ejection fraction</title>
          <units>%</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Renal Blood Flow (RBF)</title>
        <description>Renal blood flow measured with PAH clearance</description>
        <time_frame>6 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CardioPulmonaryBypass</title>
            <description>Open cardiac surgery with normothermic Cardiopulmonary Bypass at 2.5 L/min/m2.</description>
          </group>
        </group_list>
        <measure>
          <title>Renal Blood Flow (RBF)</title>
          <description>Renal blood flow measured with PAH clearance</description>
          <units>ml per minute per 1.73 m2 body surface</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre CPB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="554" spread="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CPB 30 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="524" spread="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CPB 60 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="564" spread="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post CPB (30 - 60 minutes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="558" spread="130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Repeated measures ANOVA throughout measurement period (before, during and after CPB).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.638</p_value>
            <p_value_desc>Bonferroni–Holm adjustment for multiple comparisons was used</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Glomerular Filtration Rate (GFR)</title>
        <description>GFR measured by renal extraction of 51Cr-EDTA</description>
        <time_frame>6 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CardioPulmonaryBypass</title>
            <description>Open cardiac surgery with normothermic Cardiopulmonary Bypass at 2.5 L/min/m2.</description>
          </group>
        </group_list>
        <measure>
          <title>Glomerular Filtration Rate (GFR)</title>
          <description>GFR measured by renal extraction of 51Cr-EDTA</description>
          <units>ml per minute per 1.73 m2 body surface</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before CPB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67" spread="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CPB 30 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68" spread="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CPB 60 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" spread="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post CPB (30 - 60 minutes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Repeated measures ANOVA</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.972</p_value>
            <p_value_desc>Bonferroni–Holm adjustment for multiple comparisons was used</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Renal Oxygenation</title>
        <description>Renal oxygen extraction, defined as renal oxygen consumption divided by renal oxygen delivery</description>
        <time_frame>6 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CardioPulmonaryBypass</title>
            <description>Open cardiac surgery with normothermic Cardiopulmonary Bypass at 2.5 L/min/m2.</description>
          </group>
        </group_list>
        <measure>
          <title>Renal Oxygenation</title>
          <description>Renal oxygen extraction, defined as renal oxygen consumption divided by renal oxygen delivery</description>
          <units>fraction</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre CPB</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CPB 30 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CPB 60 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post CPB (30 - 60 minutes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Repeated measures ANOVA</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Bonferroni–Holm adjustment for multiple comparisons was used</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Excretion of NAG</title>
        <description>Urinary biomarker of tubular renal injury</description>
        <time_frame>24 hours</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Development of Acute Kidney Injury (AKI)</title>
        <description>AKI according to AKIN criteria</description>
        <time_frame>72 hours</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Three days</time_frame>
      <desc>Postoperative acute kidney injury, defined as an increase in serum-creatinine ≥50 % from baseline.</desc>
      <group_list>
        <group group_id="E1">
          <title>CardioPulmonaryBypass</title>
          <description>Open cardiac surgery with normothermic Cardiopulmonary Bypass at 2.5 L/min/m2.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <description>Increase in serum-creatinine ≥50% from baseline</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lukas Lannemyr</name_or_title>
      <organization>Västra Götalandsregionen</organization>
      <phone>46313428860</phone>
      <email>lukas.lannemyr@vgregion.se</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

